Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 804,000 shares, an increase of 40.6% from the February 13th total of 571,900 shares. Based on an average trading volume of 412,700 shares, the days-to-cover ratio is presently 1.9 days. Currently, 4.9% of the company’s shares are sold short.
Insider Activity
In other news, CFO Georgios Terzis purchased 85,778 shares of the stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of $0.58 per share, with a total value of $49,751.24. Following the transaction, the chief financial officer now owns 727,263 shares in the company, valued at $421,812.54. The trade was a 13.37 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Grigorios Siokas purchased 257,334 shares of the stock in a transaction dated Friday, December 20th. The shares were purchased at an average cost of $0.58 per share, for a total transaction of $149,253.72. Following the transaction, the chief executive officer now owns 3,774,314 shares in the company, valued at approximately $2,189,102.12. The trade was a 7.32 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 1,175,618 shares of company stock valued at $701,169. 15.61% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC boosted its stake in Cosmos Health Inc. (NASDAQ:COSM – Free Report) by 29.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 193,432 shares of the company’s stock after buying an additional 43,704 shares during the period. Geode Capital Management LLC owned approximately 0.83% of Cosmos Health worth $129,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 12.61% of the company’s stock.
Cosmos Health Trading Down 1.0 %
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- Investing In Automotive Stocks
- How to Build the Ultimate Everything ETF Portfolio
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.